OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
OABI is expected to report earnings to rise 137.20% to -11 cents per share on November 17
Q3'26
Est.
$-0.12
Q2'26
Beat
by $0.07
Q3'25
Beat
by $0.02
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.03
The last earnings report on August 06 showed earnings per share of -5 cents, beating the estimate of -11 cents. With 5.96M shares outstanding, the current market capitalization sits at 491.42M.